Top

Osteoporosis International

Published in:

01-03-2013 | Letter

Lack of predictive value of FGF23 levels on pulse wave velocity

Authors: L. Desjardins, S. Liabeuf, Z. A. Massy

Published in: Osteoporosis International | Issue 3/2013

Excerpt

Dear Editor, …

Smith ER, McMahon LP, Holt SG (2012) FGF23: instability may affect accuracy and interpretation. Osteoporosis Int. doi:10.1007/s00198-012-2036-4

Desjardins L, Liabeuf S, Renard C, Lenglet A, Lemke H-D, Choukroun G, Drueke TB, Massy ZA, European Uremic Toxin (EUTox) Work Group (2011) FGF23 is independently associated with vascular calcification but not bone mineral density in patients at various CKD stages. Osteoporos Int 23:2017–2025. doi:10.1007/s00198-011-1838-0 PubMedCrossRef

Ford ML, Smith ER, Tomlinson LA, Chatterjee PK, Rajkumar C, Holt SG (2012) FGF-23 and osteoprotegerin are independently associated with myocardial damage in chronic kidney disease stages 3 and 4. Another link between chronic kidney disease–mineral bone disorder and the heart. Nephrol Dial Trans 27:727–733CrossRef

Smith ER, Ford ML, Tomlinson LA, Weaving G, Rocks BF, Rajkumar C, Holt SG (2011) Instability of fibroblast growth factor-23 (FGF-23): implications for clinical studies. Clin Chim Acta 412:1008–1011PubMedCrossRef

Gutiérrez OM, Mannstadt M, Isakova T, Rauh-Hain JA, Tamez H, Shah A, Smith K, Lee H, Thadhani R, Jüppner H, Wolf M (2008) Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis. N Engl J Med 359:584–592PubMedCrossRef

Isakova T, Xie H, Yang W, Xie D, Anderson AH, Scialla J, Wahl P, Gutiérrez OM, Steigerwalt S, He J, Schwartz S, Lo J, Ojo A, Sondheimer J, Hsu C, Lash J, Leonard M, Kusek JW, Feldman HI, Wolf M (2011) Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease. JAMA 305:2432–2439PubMedCrossRef

Title: Lack of predictive value of FGF23 levels on pulse wave velocity
Authors: L. Desjardins
S. Liabeuf
Z. A. Massy
Publication date: 01-03-2013
Publisher: Springer-Verlag
Published in: Osteoporosis International / Issue 3/2013
Print ISSN: 0937-941X
Electronic ISSN: 1433-2965
DOI: https://doi.org/10.1007/s00198-012-2037-3

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Lack of predictive value of FGF23 levels on pulse wave velocity

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 3/2013

Sarcopenia and osteopenia among 70–80-year-old home-dwelling Finnish women: prevalence and association with functional performance

FGF23: instability may affect accuracy and interpretation

Psychometric properties and osteoprotective behaviors among type 2 diabetic patients: osteoporosis self-efficacy scale Malay version (OSES-M)

Associations of vertebral deformities and osteoarthritis with back pain among Japanese women: the Hizen-Oshima study

Inhibition of osteoclast differentiation and matrix metalloproteinase production by CD4+CD25+ T cells in mice

Effects of strontium on the quality of bone apatite crystals: a paired biopsy study in postmenopausal osteoporotic women